Genprex Inc (GNPX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are mixed, with bearish moving averages and neutral RSI, while the financial performance is weak with declining net income and EPS. Although Congressman Tim Moore's past trading success and his purchase of GNPX shares may suggest some optimism, the lack of strong trading trends, poor financials, and absence of proprietary trading signals do not support a compelling buy case.

Technical Analysis

The MACD is positive and expanding, indicating a slight bullish momentum. However, the RSI is neutral at 53.505, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 1.791, with resistance at 2.448. Overall, the technical indicators suggest mixed signals with no strong upward momentum.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Congressman Tim Moore, recognized as a top-performing trader, has purchased shares of Genprex, reflecting potential optimism. The MACD is showing positive momentum.

Neutral/Negative Catalysts

The company's financial performance is weak, with a significant drop in EPS (-91.89% YoY) and net income (-11.97% YoY). Moving averages are bearish, and there are no significant trading trends from hedge funds or insiders. No proprietary trading signals are present.

Financial Performance

In Q3 2025, revenue remained at 0 with no growth. Net income dropped by -11.97% YoY to -3,799,240, and EPS fell by -91.89% YoY to -5. Gross margin remained at 0 with no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast GNPX stock price to rise

Buy

Hold

Sell

Current: 2.000

Low

Averages

High